celastrol has been researched along with Aspergillosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, N; Li, C; Lin, J; Peng, X; Sun, Q; Wang, Q; Xu, Q; Zhao, G | 1 |
| Baig, N; Feng, X; Guo, RT; Kim, BK; Li, Q; Malwal, SR; Oldfield, E; Shang, N; Shin, C; Song, J; Yao, J | 1 |
2 other study(ies) available for celastrol and Aspergillosis
| Article | Year |
|---|---|
Celastrol ameliorates Aspergillus fumigatus keratitis via inhibiting LOX-1.
Topics: Animals; Anti-Inflammatory Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Cornea; Disease Models, Animal; Female; Humans; Keratitis; Macrophages, Peritoneal; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Pentacyclic Triterpenes; Primary Cell Culture; Scavenger Receptors, Class E; Triterpenes | 2019 |
Aspergillus flavus squalene synthase as an antifungal target: Expression, activity, and inhibition.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Bridged Bicyclo Compounds, Heterocyclic; Cloning, Molecular; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Models, Molecular; Molecular Targeted Therapy; Pentacyclic Triterpenes; Tricarboxylic Acids; Triterpenes | 2019 |